Post-registration experience of nivolumab (nivo) therapy in patients with advanced hepatocellular carcinoma (HCC): An international study.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Petros Fessas, Ahmed Omar Kaseb, Yinghong Wang, Anwaar Saeed, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Uqba Khan, Bo Yu, Sonal D Paul, Neil satish Nimkar, Dominik Bettinger, Hannah Hildebrand, Yehia I. Mohamed, Yi-Hsiang Huang, Lorenza Rimassa, Celina Ang, Thomas Urban Marron, David James Pinato
Institutions: Imperial College London, The University of Texas MD Anderson Cancer Center, University of Kansas Medical Center, Mount Sinai Hospital, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, East Carolina University, Weill Cornell Medicine, Lincoln Medical Center, NewYork–Presbyterian Brooklyn Methodist Hospital, University of Freiburg, University Medical Center Freiburg, Taipei Veterans General Hospital, National Yang Ming University, Humanitas University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3030328149